Gentronix
Latest round
- Seed
Last raised
- Jun 1999
Total raised
- Undisclosed
Investors
- 2
About Gentronix
Based in Cheshire, UK, and founded in 1999, Gentronix Limited is a biotechnology company that creates screening tests to detect genetic toxins early in the medicine discovery process. In September 2024, Scantox A/S, a portfolio company of Impilo, acquired Gentronix Limited from Manchester Technology Fund, YFM Equity Partners, The University of Manchester Intellectual Property, etc. As of October 2024, Matt Tate is the Chief Executive Officer (CEO) of the company. Gentronix is a specialized research organization that provides services to predict how chemicals can be harmful, especially in areas like genetic safety and skin reactions. The company offers services, such as testing for genetic toxicity and skin safety, helping clients prove that the chemicals are safe and observe with regulations. Gentronix focuses on maintaining strong scientific standards and uses advanced methods to identify potential hazards early in product development.
Who invested in Gentronix
2 investors across 1 round
See all investors in Gentronix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 1, 1999
Amount
Undisclosed
Investors
Questions about Gentronix
Who invested in Gentronix?
Gentronix has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gentronix raised?
Gentronix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gentronix last raise money?
Gentronix's most recent round on record is a Seed, in Jun 1999.
What does Gentronix do?
Based in Cheshire, UK, and founded in 1999, Gentronix Limited is a biotechnology company that creates screening tests to detect genetic toxins early in the medicine discovery process.
Where is Gentronix headquartered?
Gentronix is headquartered in Cheshire, UK.
Which VCs invest in companies like Gentronix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Gentronix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Gentronix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.